Related references
Note: Only part of the references are listed.MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Epigenetic gene silencing in the Wnt pathway in breast cancer
George J. Klarmann et al.
EPIGENETICS (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNAs modulate the chemosensitivity of tumor cells
Paul E. Blower et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
Kelly H. Salter et al.
PLOS ONE (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
The role of site accessibility in microRNA target recognition
Michael Kertesz et al.
NATURE GENETICS (2007)
A systems biology approach for pathway level analysis
Sorin Draghici et al.
GENOME RESEARCH (2007)
microRNAs and cancer: role in tumorigenesis, patient classification and therapy
E. Hernando
CLINICAL & TRANSLATIONAL ONCOLOGY (2007)
Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
Meiyun Fan et al.
CANCER RESEARCH (2006)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-α
XH Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
The widespread impact of mammalian microRNAs on mRNA repression and evolution
KKH Farh et al.
SCIENCE (2005)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
S Bagga et al.
CELL (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
PS Eis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Clinical development of fulvestrant ('Faslodex')
A Howell et al.
CANCER TREATMENT REVIEWS (2005)
Role of transforming growth factor β in breast carcinogenesis
JR Benson
LANCET ONCOLOGY (2004)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
A custom microarray platform for analysis of microRNA gene expression
JM Thomson et al.
NATURE METHODS (2004)
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells
Y Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the anti proliferative activity of ICI 182,780 in ERα-positive breast cancer cells
MY Fan et al.
MOLECULAR ENDOCRINOLOGY (2003)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
